Salarius Pharmaceuticals Competitors and Similar CompaniesClear all

Salarius Pharmaceuticals's competitors and similar companies include Medicenna Therapeutics, MetaStat and ImmunoCellular Therapeutics.

	Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.	Medicenna Therapeutics Medicenna Therapeutics is an immunotherapy company focused on oncology.	MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.	ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.
Founding Date	Founding Date 2011	Founding Date 2012	Founding Date 2010	Founding Date 2006
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech clinical research drug development healthtech medical devices medical diagnostics oncology pharma therapy
Locations	Locations Houston, US HQ	Locations HQ	Locations Boston, US HQ	Locations Calabasas, US HQ
Employees	Employees 2	Employees 7	Employees 6	Employees 357% decrease
Valuation ($)	Valuation ($) 2.4 m	Valuation ($) 122.2 m	Valuation ($) 20.6 k	Valuation ($) 15.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $23.3k (FY, 2018)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($18.4m) (FY, 2026)	Net income ($3.2m) (FY, 2018)	Net income ($14.3m) (FY, 2017)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 7.5m	Total funding raised $ 350k	Total funding raised $ 32.5m